Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: A randomised controlled trial

Growth Hormone and IGF Research

Volumn 16, Issue 5-6, 2006, Pages 308-317

  Giannoulis, Manthos G ^a   Jackson, Nicola ^a   Shojaee Moradie, Fariba ^a   Sonksen, Peter H ^a   Martin, Finbarr C ^a   Umpleby, A Margot ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Elderly; Growth hormone; Plasma lipids; Testosterone; VLDL apoB

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; CARBON 13; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RECOMBINANT GROWTH HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LOW DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN B-100; BODY COMPOSITION; DOUBLE-BLIND METHOD; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; LIPOPROTEINS, VLDL; MALE; RECOMBINANT PROTEINS; TESTOSTERONE;

EID: 33751259426     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.08.001     Document Type: Article

References (51)

1. Iranmanesh A., Lizzarlde G., and Veldhuis J.D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory burst and half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73 (1991) 1081-1088
2. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 86 (2001) 724-731
3. Siervogel R.M., Wisemandle W., Maynard L.M., et al. Serial changes in body composition throughout adulthood and their relationships to changes in lipid and lipoprotein levels. The Fels Longitudinal Study. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1759-1764
4. Millar J.S., Lichtenstein A.H., Cuchel M., et al. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. J. Lipid. Res. 36 (1995) 1155-1167
5. Couillard C., Lemieux S., Moorjani S., et al. Associations between 12 year changes in body fatness and lipoprotein-lipid levels in men and women of the Quebec Family Study. Int. J. Obes. 20 (1996) 1081-1088
6. Dixon J.L., and Ginsberg H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid. Res. 34 (1993) 167-179
7. Sniderman A.D., and Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler. Thromb. Vasc. Biol. 13 (1993) 629-636
8. Carroll P.V., Christ E.R., Bengtsson B.A., et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J. Clin. Endocrinol. Metab. 83 (1998) 382-395
9. Snyder P.J., Peachey H., Berlin J.A., et al. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am. J. Med. 111 (2001) 255-260
10. Christ E.R., Cummings M.H., Albany E., et al. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. J. Clin. Endocrinol. Metab. 1 (1999) 307-316
11. Christ E.R., Cummings M.H., Jackson N., et al. Effects of growth hormone replacement therapy on LDL apolipoprotein B100 kinetics in adult patients with growth hormone deficiency: a stable isotope study. J. Clin. Endocrinol. Metab. 89 (2004) 1801-1807
12. Tenover J.S. Effects of testosterone supplementation in the aging male. J. Clin. Endocrinol. Metab. 75 (1992) 1092-1098
13. Heymsfield S.B., Wang Z., Baumgartner R.N., and Ross R. Human body composition: advances in models and methods. Annu. Rev. Nu. 17 (1997) 527-558
14. Cummings M.H., Watts G.F., Umpleby A.M., et al. Acute hyperinsulinaemia decreases the hepatic secretion of very low density lipoprotein B100 in type 2 diabetes mellitus: a stable isotope study. Diabetes 44 (1995) 1059-1065
15. Kane J.P., Sata T., and Hamilton R.L. Apoprotein composition of very low density lipoproteins of human serum. J. Clin. Invest. 56 (1975) 1622-1634
16. Sonksen P.H. Double-antibody technique for the simultaneous assay of insulin and growth hormone. In: Antoniades H.N. (Ed). Hormones in Human Blood (1976), Harvard University Press, Cambridge (Mass), London 176-199
17. Riches F.M., Watts G.F., Naoumova R.P., Kelly J.M., Croft K.D., and Thompson G.R. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 414-423
18. Matthews D.E., Schwartz H.P., Yand R.D., Motil K.J., and Bier D. Relationship of plasma leucine and α-ketoisocaproate during L[1-13C] leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31 (1982) 1105-1112
19. Pearson T.C., Guthrie D.L., Simpson J., et al. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br. J. Haematol. 89 (1995) 748-756
20. Giannoulis M.G., Sonksen P.H., Umpleby M., et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 91 (2006) 477-484
21. Olivecrona H., Ericsson S., and Angelin B. Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men. J. Clin. Endocrinol. Metab. 80 (1995) 1113-1117
22. Lind S., Rudling M., Ericsson S., et al. Growth hormone induces low-density lipoprotein clearance but not Bile Acid synthesis in humans. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 349-356
23. Salomon F., Cuneo R.C., Hesp R., and Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321 (1989) 1797-1803
24. Russell-Jones D.L., Watts G.F., et al. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin. Endocrinol. (Oxf.) 41 (1994) 345-350
25. Simon D., Charles M.A., Nahoul K., et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the telecom study. J. Clin. Endocrinol. Metab. 82 (1997) 682-685
26. Ozata M., Yildirimkaya M., Bulur M., et al. Effects of gonadotropin and testosterone treatments on lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. J. Clin. Endocrinol. Metab. 81 (1996) 3372-3378
27. Tan K.C.B., Shiu S.W.M., Pang R.W.C., and Kung A.W.C. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-1 containing lipoproteins. Clin. Endocrinol. (Oxf.) 48 (1998) 187-194
28. Dobs A.S., Bachorik P.S., Arver S., et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. J. Clin. Endocrinol. Metab. 86 (2001) 026-33
29. Zgliczynski S., Ossowski M., Slowinska-Srzednicka J., et al. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men. Atherosclerosis 21 (1996) 35-43
30. Howell S.J., Radford J.A., Adams J.E., Smets E.M., Warburton R., and Shalet S.M. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin. Endocrinol. (Oxf.) 55 (2001) 315-324
31. Singh A.B., Hsia S., Alaupovic P., et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J. Clin. Endocrinol. Metab. 87 (2002) 136-143
32. Whitsel E.A., Boyko E.J., Matsumoto A.M., Anawalt B.D., and Siscovick D.S. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am. J. Med. 111 (2001) 261-269
33. Ly L.P., Jimenez M., Zhuang T.N., Celermajer D.S., Conway A.J., and Handelsman D.J. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J. Clin. Endocrinol. Metab. 86 (2001) 4078-4088
34. Kenny A.M., Prestwood K.M., Gruman C.A., Fabregas G., Biskup B., and Mansoor G. Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels. J. Gerontol. A Biol. Sci. Med. Sci. 57 (2002) M460-M465
35. Marcovina S.M., Lippi G., J Bagatell C., and Bremner W.J. Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level. Atherosclerosis 122 (1996) 89-95
36. Marin P., Oden B., and Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80 (1995) 239-243
37. Johannsson G., Mårin P., Lönn L., et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 82 (1997) 727-734
38. Ottosson M., Vikman-Adolfsson K., Enerbäck S., Elander A., Björntorp P., and Edén S. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J. Clin. Endocrinol. Metab. 80 (1995) 936-941
39. Yang S., Xu X., Bjorntorp P., and Eden S. Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J. Endocrinol. 147 (1995) 147-152
40. Fowelin J., Attvall S., Lager I., and Bengtsson B.-Å. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42 (1993) 1443-1447
41. ter Maaten J.C., Voorburg A., de Vries P.M., M ter Wee P., Donker A.J., and Gans R.O. Relationship between insulin's haemodynamic effects and insulin-mediated glucose uptake. Eur. J. Clin. Invest. 28 (1998) 279-284
42. Christ E.R., Cummings M.H., Westwood N.B., Sawyer B.M., Pearson T.C., Sonksen P.H., and Russell-Jones D.L. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 82 (1997) 2985-2990
43. Cuneo R.C., Salomon F., Wiles C.M., Hesp R., and Sonksen P.H. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J. Appl. Physiol. 70 (1991) 695-700
44. Gola M., Bonadonna S., Doga M., and Giustina A. Growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90 (2005) 1864-1870
45. Christ E.R., Chowienczyk P.J., Sonksen P.H., and Russel-Jones D.L. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity. Clin. Endocrinol. (Oxf.) 51 (1999) 21-25
46. Riches F.M., Watts G.F., Hua J., Stewart G.R., Naoumova R.P., and Barrett P.H.R. Reduction in visceral adipose tissue Is associated with improvement in apolipoprotein B-100 metabolism in obese men. J. Clin. Endocrinol. Metab. 84 (1999) 2854-2861
47. Brummer R.J., Lonn L., Kvist H., Grangard U., Bengtsson B.A., and Sjostrom L. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. Eur. J. Clin. Invest. 23 (1993) 199-205
48. Tan K.C.B., Shiu S.W.M., and Kung A.W.C. Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 51 (1999) 765-769
49. Sorva R., Kussi T., Taskinen M.R., Perheentupa J., and Nikkila E.A. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 69 (1988) 191-197
50. Anderson L.A., McTernan P.G., Harte A.L., Barnett A.H., and Kumar S. The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes. Obes. Metab. 4 (2002) 209-213
51. Marin P., Lonn L., Andersson B., Oden B., Olbe L., Bengtsson B.A., and Bjorntorp P. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J. Clin. Endocrinol. Metab. 81 (1996) 1018-1022